Follitropin Alfa (Gonal-F) Shortage Update: What Patients Need to Know in 2026

If you're a fertility patient trying to fill a Gonal-F prescription in 2026, you've likely already discovered it's not as simple as walking into a pharmacy. Supply constraints on follitropin alfa (Gonal-F) have created an ongoing challenge for patients and providers alike — and the situation continues to be a concern heading through the year. Here's what you need to know.

Is Gonal-F in Shortage Right Now (2026)?

Gonal-F is not always formally listed on the FDA Drug Shortage Database. However, real-world availability has been consistently tight — particularly for the 900 IU Redi-ject pen, the most commonly prescribed format. The availability picture varies significantly:

Specialty fertility pharmacies often have stock that retail chains don't

Stock can change from week to week — even day to day

Geographic availability varies — some regions are better supplied than others

The 300 IU and 450 IU pens, and multi-dose vials, may be available when the 900 IU pen is not

Bottom line: Plan ahead. Don't wait until the day you need to start injections.

What's Causing the Gonal-F Supply Problem?

Several structural factors are behind the ongoing availability issues:

No US biosimilar competition. Unlike Europe, where biosimilars like Ovaleap and Bemfola offer alternative options, the US has no FDA-approved biosimilar for follitropin alfa as of 2026. EMD Serono is the sole US supplier.

Complex biologic manufacturing. Gonal-F is produced using living CHO cell cultures — a slow, precise process that can't be rapidly scaled when demand spikes.

Rising IVF demand. Expanded insurance mandates in multiple states and growing cultural awareness of fertility treatment are driving steady increases in the number of IVF cycles each year — demand the current supply chain is struggling to match.

Specialty distribution only. Gonal-F requires refrigeration and is distributed through specialty pharmacy channels, creating fewer access points than a typical retail medication.

Current Cash Prices for Gonal-F in 2026

Gonal-F is one of the most expensive fertility medications on the market. Here's what patients are paying in 2026 without insurance:

Gonal-F RFF Redi-ject 900 IU pen: approximately $900 to $1,500 per pen

Gonal-F RFF Redi-ject 450 IU pen: approximately $500 to $800 per pen

A typical IVF cycle uses 1,500 to 5,000+ IU total — meaning Gonal-F alone can cost $1,800 to $6,000 or more per cycle

Prices vary between specialty pharmacies, sometimes by $100–$300 or more per pen — so comparing quotes from multiple pharmacies is always worth doing.

What Should Patients Do Right Now?

Here are the most effective steps fertility patients can take:

Start your search early. Begin looking for Gonal-F 1–2 weeks before your injection start date. Don't wait until day one.

Contact specialty fertility pharmacies. Freedom Fertility, Encompass Rx, Alto Pharmacy, and Village Fertility Pharmacy typically have better stock than retail chains.

Alert your fertility clinic. Your nurse coordinator can help locate stock through clinic dispensaries or preferred pharmacy networks.

Call EMD Serono Fertility Lifelines: 1-866-538-7879 for help locating stock.

Ask about switching formats. If the 900 IU pen is unavailable, your doctor may be able to adjust your prescription to the 450 IU or 300 IU pen or multi-dose vials.

Discuss alternatives. Follistim AQ (follitropin beta) is the most direct substitute if Gonal-F is truly unavailable in your area.

How medfinder Helps Patients During Shortages

Rather than spending hours on the phone during a stressful fertility cycle, medfinder contacts pharmacies near you to find which ones have Gonal-F in stock. Enter your medication, dosage, and location — medfinder does the searching and texts you the results. For more strategies, see our guide on how to find Gonal-F near you.